Epilepsy is a common neurological disorder characterized by recurrent and unprovoked seizures. Genetic factors are thought to play a major role, either as multiple risk factors in common epilepsies or as single gene variants in rare monogenic epilepsies. The latter are more often found in individuals with early seizure onset and comorbidities. This review finds that, as technology has accelerated our knowledge on monogenic epilepsies, we slowly move from diagnostics to the clinical application of a genetic diagnosis to optimize treatment. Thus, sometimes a genetic diagnosis provides a targeted treatment strategy.
|Translated title of the contribution||Genetic factors provide individualised targeted treatment of epilepsy|
|Journal||Ugeskrift for Laeger|
|Publication status||Published - 27. Jun 2022|